TARG-9

N/A

Report date: 2022/06/07 09:59:37

Base Information

Drug NameTARG-9
Drug Alias NameTARG-9
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionIntegrin alpha10/beta1 modulators
TargetsIntegrin alpha10/beta1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTarginta AB
China Registration ClassN/A

Develop Information

Active CompaniesTarginta AB
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A